Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: Implication of a dopamine D 1-dependent mechanism

Neurobiology of Disease

Volumn 20, Issue 2, 2005, Pages 450-460

  St Hilaire, Michel ^a   Landry, Éric ^a   Lévesque, Daniel ^a,b   Rouillard, Claude ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Direct pathway; Dopamine receptor; Dynorphin; Enkephalin; Indirect pathway; Neurotensin; Nur77; Parkinson's disease; Sensitization; Transcription factor

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR; DYNORPHIN; ENKEPHALIN; GLUCOSE TRANSPORTER 1; LEVODOPA; MESSENGER RNA; NEUROTENSIN; NUCLEAR RECEPTOR NUR77; NUCLEIC ACID BINDING PROTEIN; OXIDOPAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; DOPAMINERGIC ACTIVITY; DRUG RECEPTOR BINDING; DRUG SENSITIZATION; GENE CONTROL; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; SENSORIMOTOR CORTEX; STRIATE CORTEX; THALAMUS;

ANIMALS; CORPUS STRIATUM; DENERVATION; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DOPAMINE; DOPAMINE ANTAGONISTS; DYNORPHINS; ENKEPHALINS; EXCITATORY AMINO ACID TRANSPORTER 2; GENE EXPRESSION REGULATION; LEVODOPA; MALE; NEURONS; NEUROTENSIN; PARKINSON DISEASE; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D3; RECEPTORS, STEROID; RNA, MESSENGER; TRANSCRIPTION FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 26944478179     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2005.04.001     Document Type: Article

References (54)

1. M.R. Adams, E.P. Brandon, E.H. Chartoff, R.L. Idzerda, D.M. Dorsa, and G.S. McKnight Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice Proc. Natl. Acad. Sci. U. S. A. 94 1997 12157 12161
2. M. Andersson, A. Hilbertson, and M.A. Cenci Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease Neurobiol. Dis. 6 1999 461 474
3. M. Andersson, C. Konradi, and M.A. Cenci cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum J. Neurosci. 21 2001 9930 9943
4. J.J. Bacci, P. Kachidian, L. Kerkerian-Le Goff, and P. Salin Intralaminar thalamic nuclei lesions: widespread impact on dopamine denervation-mediated cellular defects in the rat basal ganglia J. Neuropathol. Exp. Neurol. 63 2004 20 31
5. G. Beaudry, M.-C. Langlois, I. Weppe, C. Rouillard, and D. Lévesque Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor Nerve Growth Factor-inducible B by haloperidol and clozapine in the rat forebrain J. Neurochem. 75 2000 1694 1702
6. H.W. Berendse, Y. Galis-de Graaf, and H.J. Groenewegen Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat J. Comp. Neurol. 316 1992 314 347
7. C. Betancur, W. Rostene, and A. Berod Chronic cocaine increases neurotensin gene expression in the shell of the nucleus accumbens and in discrete regions of the striatum Mol. Brain Res. 44 1997 334 340
8. C. Betancur, I. Lepee-Lorgeoux, M. Cazillis, D. Accili, S. Fuchs, and W. Rostene Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D-3 receptor deficient mice Neuropsychopharmacology 24 2001 170 182
9. R. Bordet, S. Ridray, S. Carboni, J. Diaz, P. Sokoloff, and J.C. Schwartz Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa Proc. Natl. Acad. Sci. U. S. A. 94 1997 3363 3367
10. R. Bordet, S. Ridray, J.C. Schwartz, and P. Sokoloff Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats Eur J. Neurosci. 12 2000 2117 2123
11. J.S. Brog, and D.S. Zahm Morphology and Fos immunoreactivity reveal two subpopulations of striatal neurotensin neurons following acute 6-hydroxydopamine lesions and reserpine administration Neuroscience 65 1995 71 86
12. J.M. Brotchie, B. Henry, C.J. Hille, and A.R. Crossman Opioid peptide precursor expression in animal models of dystonia secondary to dopamine-replacement therapy in Parkinson's disease Adv. Neurol. 78 1998 41 52
13. F. Calon, R. Grondin, M. Morissette, M. Goulet, P.J. Blanchet, T. Di Paolo, and P.J. Bédard Molecular basis of levodopa-induced dyskinesias Ann. Neurol. 47 2000 S70 S78
14. 2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization J. Neurosci. 22 2002 6218 6227
15. M.-N. Castel, P. Morino, I. Nylander, L. Terenius, and T. Hökfelt Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat Eur. J. Pharmacol. 262 1994 1 10
16. M.A. Cenci, C.S. Lee, and A. Bjorklund l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA Eur. J. Neurosci. 10 1998 2694 2706
17. M.A. Cenci, A. Tranberg, M. Andersson, and A. Hilbertson Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic l-DOPA treatment Neuroscience 94 1999 515 527
18. J.P. Doucet, Y. Nakabeppu, P.J. Bedard, B.T. Hope, E.J. Nestler, B.J. Jasmin, J.S. Chen, M.J. Iadarola, M. St Jean, N. Wigle, P. Blanchet, R. Grondin, and G.S. Robertson Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum Eur. J. Neurosci. 8 1996 365 381
19. T.M. Engber, Z. Susel, S. Kuo, C.R. Gerfen, and T.N. Chase Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats Brain Res. 552 1991 113 118
20. I. Éthier, G. Beaudry, M. St-Hilaire, J. Milbrandt, C. Rouillard, and D. Lévesque The transcription factor NGFI-B (Nur77) and retinoids play a critical role in acute neuroleptic-induced extrapyramidal effect and neuropeptide gene expression Neuropsychopharmacology 29 2004 335 346
21. C.R. Gerfen Dopamine-mediated gene regulation in models of Parkinson's disease Ann. Neurol. 47 2000 S42 S52
22. C.R. Gerfen Molecular effects of dopamine on striatal-projection pathways Trends Neurosci. 23 2000 S64 S70
23. C.R. Gerfen D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease Neuroscientist 9 2003 455 462
24. C.R. Gerfen, S. Miyachi, R. Paletzki, and P. Brown D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase J. Neurosci. 22 2002 5042 5054
25. O. Guillin, J. Diaz, J.-C. Schwartz, and P. Sokoloff BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization Nature 411 2001 86 89
26. G.R. Hanson, and K.A. Keefe Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway Mol. Brain Res. 66 1999 111 121
27. M.-C. Langlois, G. Beaudry, C. Rouillard, and D. Lévesque Impact of neuroleptic administration on coordinate expression of nuclear receptors in the cortex and striatal complex of the rat brain Neurosci. 106 2001 117 128
28. D. Lévesque, M.-P. Martres, J. Diaz, N. Griffon, C.H. Lammers, P. Sokoloff, and J.-C. Schwartz A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons Proc. Natl. Acad. Sci. U. S. A. 92 1995 1719 1723
29. J.-C. Liévens, P. Salin, A. Nieoullon, and L. Kerkarian-Le Goff Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum J. Neurochem. 79 2001 893 902
30. N. Lindefors, and U. Ungerstedt Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons Neurosci. Lett. 115 1990 248 252
31. A.J. McGeorge, and R.L.M.K. Faull The organisation of the projection from the cerebral cortex to the striatum in the rat Neuroscience 29 1989 503 537
32. K.M. Merchant, and D.M. Dorsa Differential induction of neurotensin and c-fos gene expression by typical vs. atypical antipsychotics Proc. Natl. Acad. Sci. U. S. A. 90 1993 3447 3451
33. C.K. Meshul, N. Emre, C.M. Nakamura, C. Allen, M.K. Donohue, and J.F. Buckman Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion Neuroscience 88 1999 1 16
34. D.D. Newman, N. Rajakumar, B.A. Flumerfelt, and A.J. Stoessl A kappa opioid antagonist blocks sensitization in a rodent model of Parkinson's disease NeuroReport 8 1997 669 672
35. N.K. Parelkar, and J.Q. Wang Preproenkephalin mRNA expression in rat dorsal striatum induced by selective activation of metabotropic glutamate receptor subtype-5 Synapse 47 2003 255 261
36. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1986 Academic Press San Diego
37. G. Pines, N.C. Danbolt, M. Bjoras, Y. Zhang, A. Bendahan, L. Eide, H. Koepsell, J. Storm-Mathisen, E. Seeberg, and B.I. Kanner Cloning and expression of a rat brain l-glutamate transporter Nature 360 1992 464 467
38. S. Robelet, C. Melon, B. Guillet, P. Salin, and L. Kerkerian-Le Goff Chronic l-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease Eur. J. Neurosci. 20 2004 1255 1266
39. C. Rouillard, P.J. Bédard, P. Falardeau, and T. Di Paolo Behavioral and biochemical evidence for different effect of repeated administration of l-DOPA and bromocriptine on denervated versus non-denervated striatal dopamine receptors Neuropharmacology 26 1987 1601 1606
40. P. Salin, and P. Kachidian Thalamo-striatal deafferentation affects preproenkephalin but not preprotachykinin gene expression in the rat striatum Mol. Brain Res. 57 1998 257 265
41. Y. Smith, D.V. Raju, J.F. Pare, and M. Sidibe The thalamostriatal system: a highly specific network of the basal ganglia circuitry Trends Neurosci. 27 2004 520 527
42. M. St-Hilaire, É. Landry, D. Lévesque, and C. Rouillard Denervation and repeated l-DOPA induce a coordinate expression of the transcription factor NGFI-B in striatal projection pathways in hemi-parkinsonian rats Neurobiol. Dis. 14 2003 98 109
43. A.J. Stoessl Effects of neurotensin in a rodent model of tardive dyskinesia Neuropharmacology 34 1995 457 462
44. D.J. Surmeier, A. Reiner, M.S. Levine, and M.A. Ariano Are neostriatal dopamine receptors co-localized? Trends Neurosci. 16 1993 299 305
45. R. Torp, N.C. Danbolt, E. Babaie, M. Bjoras, E. Seeberg, J. Storm-Mathisen, and O.P. Ottersen Differential expression of two glial glutamate transporters in the rat brain: an in situ hybridization study Eur. J. Neurosci. 6 1994 936 942
46. 3 receptor antisense reduces neuropeptide mRNA levels in rat nucleus accumbens NeuroReport 8 1997 3901 3905
47. M. Tremblay, C. Rouillard, and D. Lévesque Dopamine D3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain Synapse 32 1999 51 57
48. 1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons Synapse 43 2002 1 11
49. J.M. Van Kampen, and A.J. Stoessl Effects of oligonucleotide antisense to dopamine D1A receptor messenger RNA in a rodent model of levodopa-induced dyskinesia Neuroscience 98 2000 61 67
50. 3 receptor mRNA in a rodent model of behavioural sensitization to levodopa Neuroscience 116 2003 307 314
51. J. Wardas, M. Pietraszek, S. Wolfarth, and K. Ossowska The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: implications for the therapy of Parkinson's disease Neuroscience 122 2003 747 756
52. J.E. Westin, M. Andersson, M. Lundblad, and M.A. Cenci Persistent changes in striatal gene expression induced by long term l-DOPA treatment in a rat model of Parkinson's disease Eur. J. Neurosci. 14 2001 1171 1176
53. I. Willuhn, W. Sun, and H. Steiner Topography of cocaine-induced gene regulation in the rat striatum: relationship to cortical inputs and role of behavioural context Eur. J. Neurosci. 17 2003 1053 1066
54. K. Yoshikawa, C. Williams, and S.L. Sabol Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system J. Biol. Chem. 259 1984 14301 14308